College Station, TX, United States of America

Weimin Teng

This inventor holds 1 USPTO granted patent. Top assignee: Rhone-Poulenc Agro. Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Weimin Teng: Innovator in Agrobacterium-Mediated Transformation of Monocots

Introduction

Weimin Teng is a notable inventor based in College Station, TX (US). She has made significant contributions to the field of biotechnology, particularly in the transformation of monocots using Agrobacterium. Her innovative methods have the potential to advance agricultural practices and improve crop yields.

Latest Patents

Weimin Teng holds a patent for her invention titled "Agrobacterium-mediated transformation of monocots." This patent provides methods for Agrobacterium-mediated transformation of monocots, enabling the creation of transgenic monocots. The invention also includes methods for producing seeds and progeny from these transgenic plants. She has 1 patent to her name.

Career Highlights

Weimin Teng is associated with Rhone-Poulenc Agro, where she has been instrumental in developing biotechnological solutions for agriculture. Her work focuses on enhancing the genetic transformation processes that can lead to improved crop varieties.

Collaborations

Throughout her career, Weimin has collaborated with esteemed colleagues, including Jinjiang Dong and Timothy C Hall. These partnerships have fostered innovation and contributed to the advancement of agricultural biotechnology.

Conclusion

Weimin Teng's contributions to Agrobacterium-mediated transformation of monocots highlight her role as a leading inventor in the field of biotechnology. Her work not only showcases her innovative spirit but also has the potential to impact agricultural practices significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…